Inhibition of endogenous reverse transcriptase antagonizes human tumor growth

Oncogene

Volumn 24, Issue 24, 2005, Pages 3923-3931

  Sciamanna, Ilaria ^a   Landriscina, Matteo ^b,f   Pittoggi, Carmine ^a   Quirino, Michela ^b   Mearelli, Cristina ^a   Beraldi, Rosanna ^c   Mattei, Elisabetta ^d   Serafino, Annalucia ^d   Cassano, Alessandra ^b   Sinibaldi Vallebona, Paola ^e   Garaci, Enrico ^e   Barone, Carlo ^b   Spadafora, Corrado ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d CNR   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Anticancer therapy; Differentiation; Endogenous reverse transcriptase; Proliferation; RNAi; Tumor growth

Indexed keywords

RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; BROXURIDINE; ENZYME INHIBITOR; SMALL INTERFERING RNA;

ARTICLE; CANCER THERAPY; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; EMBRYO CELL; ENZYME INHIBITION; GENE TARGETING; GENETIC EPIGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MELANOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; REGULATOR GENE; RETROPOSON; TUMOR GROWTH; CELL CYCLE; CELL DIVISION; CONFOCAL MICROSCOPY; DRUG EFFECT; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALIA; MUS MUSCULUS;

BROMODEOXYURIDINE; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; ENZYME INHIBITORS; HUMANS; MELANOMA; MICROSCOPY, CONFOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; RNA-DIRECTED DNA POLYMERASE;

EID: 20544437829     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208562     Document Type: Article

References (40)

1. Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV and Kazazian Jr HH. (2003). Proc. Natl. Acad. Sci. USA, 100, 5280-5285.
2. Crone TM, Schalles SL, Benedict CM, Pan W, Ren L, Loy SE, Isom H and Clawson GA. (1999). Hepathology, 29, 1114-1123.
3. Damm K, Hemmann U, Garin-Chesa P, Hauel N, Kauffmann I, Priepke H, Niestroj C, Daiber C, Enekel B, Guilliard B, Lauritsch I, Muller E, Pascolo E, Sauter G, Pantic M, Martens UM, Wenz C, Lingner J, Kraut N, Rettig WJ and Schnapp A. (2001). EMBO J., 20, 6958-6968.
4. Deininger PL, Moran JV, Batzer MA and Kazazian HH. (2003). Curr. Opin. Gen. Dev., 13, 651-658.
5. Deragon JM, Sinnett D and Labuda D. (1990). EMBO J., 9, 3363-3368.
6. Di Marzo Veronese F, Copeland TD, De Vico AL, Rahman R, Oroszlan S, Gallo RC and Sarngadharan MG. (1986). Science, 231, 1289-1291.
7. Egger G, Liang G, Aparicio A and Jones PA. (2004). Nature, 429, 457-463.
8. Ergun S, Buschmann C, Heukeshoven J, Dammann K, Schnieders F, Lauke H, Chalajour F, Nerbil K, Stratling WH and Schumann GG. (2004). J. Biol. Chem., 279, 27753-27763.
9. Friedlander A and Patarca R. (1999). Crit. Rev. Oncogenesis, 10, 129-159.
10. Giordano R, Magnano AR, Zaccagnini G, Pittoggi C, Moscufo N, Lorenzini R and Spadafora C. (2000). J. Cell Biol., 148, 1107-1113.
11. Hagan CR and Rudin CM. (2002). Am. J. Pharmacogenomics., 2, 25-36.
12. Hagan CR, Sheffield RF and Rudin CM. (2003). Nat. Genet., 35, 219-220.
13. Hsu MY, Meier FE, Nesbit M, Hsu JY, Van Belle P, Elder DE and Herlyn M. (2000). Am. J. Pathol., 156, 1515-1525.
14. Khan AS, Muller J and Sears JF. (2001). Virus Res., 79, 39-45.
15. Kiessling AA, Crowell R and Fox C. (1989). Proc. Acad. Natl. Sci. USA, 86, 5109-5113.
16. Kuo KW, Sheu HM, Huang YS and Leung WC. (1998). Biochem. Biophys. Res. Commun., 253, 566-570.
17. Li L, Connelly MC, Wetmore C, Curran T and Morgan JI. (2003). Cancer Res., 63, 2733-2736.
18. Li TH and Schmid CW. (2001). Gene, 276, 135-141.
19. Lilja H. (2003). Urology, 62 (Suppl 1), 27-33.
20. Linja MJ, Savinainem KJ, Saramaki OR, Tammela TL, Vessella RL and Visakorpi T. (2001). Cancer Res., 61, 3550-3555.
21. Lotem J and Sachs L. (2002). Cancer Biol., 12, 339-346.
22. Mangiacasale R, Pittoggi C, Sciamanna I, Careddu A, Mattel E, Lorenzini R, Travaglini L, Landriscina M, Barone C, Nervi C, Lavia P and Spadafora C. (2003). Oncogene, 22, 2750-2761.
23. Martin SL. (1991). Mol. Cell. Biol., 11, 4804-4807.
24. Martin SL and Branciforte D. (1993). Mol. Cell. Biol., 13, 5383-5392.
25. Melino G, Sinibaldi Vallebona P, D'Atri S, Annichiarico-Petruzzelli M, Rasi G, Catani MV, Tartaglia MI, Vernole P, Spagnoli LG, Finazzi-Agrò A and Garaci E. (1993). Clin. Chem. Enzyme Comms., 6, 105-119.
26. Mwenda JM. (1993). Cell. Mol. Biol., 39, 317-328.
27. Osborne CS, Chalakova L, Brown KE, Carter D, Horton A, Debrand E, Goyenechea B, Mitchell JA, Lopes S, Reik W and Fraser P. (2004). Nat. Genet., 36, 1065-1071.
28. Ostertag EM and Kazazian Jr HH. (2001). Annu. Rev. Genet., 35, 501-538.
29. Packer AI, Manova K and Bacharova RF. (1993). Dev. Biol., 157, 281-283.
30. Pittoggi C, Sciamanna I, Mattei E, Beraldi R, Lobascio AM, Mai A, Quaglia MG, Lorenzini R and Spadafora C. (2003). Mol. Reprod. Dev., 66, 225-236.
31. Pyra H, Boni J and Schupbach J. (1994). Proc. Natl. Acad. Sci. USA, 91, 1544-1548.
32. Portsmouth S, Stebbing J, Gill J, Mandalia S, Bower M, Nelson M, Bower M and Gazzard B. (2003). AIDS, 17, F17-F22.
33. Poznanski AA and Calarco PG. (1991). Dev. Biol., 143, 271-281.
34. Ren J, Nichols C, Bird L, Chamberlain P, Weaver K, Short S, Stuart DI and Stammers DK. (2001). J. Mol. Biol., 312, 795-805.
35. Sauane M, Gopalkrishnan RV, Sarkar D, Su ZZ, Lebedeva IV, Dent P, Pestka S and Fisher PB. (2003). Cyt. Growth Factor Rev., 14, 35-51.
36. Sauter ER, Yeo UC, Von Stemm A, Zhu W, Litwin S, Tichansky DS, Pistritto G, Nesbit M, Pinkel D, Herl M and Bastian BC. (2002). Cancer Res., 62, 3200-3206.
37. Schramke V and Allshire R. (2003). Science, 301, 1069-1074.
38. Tirelli U and Bernardi D. (2001). Eur. J. Cancer., 37, 1320-1324.
39. Umekita Y, Hiipakka RA, Koknotis JM and Shutsung L. (1996). Proc. Natl. Acad. Sci. USA, 93, 11802-11807.
40. Utikal J, Leiter U, Udart M, Kaskel P, Peter RU and Krahn GM. (2002). Cancer Invest., 20, 914-921.